VPHIF (Valeo Pharma) Inventory Turnover: 1.65 (As of Jul. 2024)

What is Valeo Pharma Inventory Turnover?

Valeo Pharma VPHIF -99.00% 12 Inventory Turnover is 1.65 as of Jul. 2024. GuruFocus rates VPHIF with a GF Score™ of 12/100.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Valeo Pharma's Cost of Goods Sold for the three months ended in Jul. 2024 was $6.98 Mil. Valeo Pharma's Average Total Inventories for the quarter that ended in Jul. 2024 was $4.22 Mil. Valeo Pharma's Inventory Turnover for the quarter that ended in Jul. 2024 was 1.65.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Valeo Pharma's Days Inventory for the three months ended in Jul. 2024 was 55.14.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Valeo Pharma's Inventory-to-Revenue for the quarter that ended in Jul. 2024 was 0.46.

Valeo Pharma (OTCPK:VPHIF) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Valeo Pharma's Days Inventory for the three months ended in Jul. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Jul. 2024 )	/	Cost of Goods Sold (Q: Jul. 2024 )	*	Days in Period
	=	4.2155	/	6.976	*	365 / 4
	=	55.14

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Valeo Pharma's Inventory to Revenue for the quarter that ended in Jul. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Jul. 2024 )	/	Revenue (Q: Jul. 2024 )
	=	4.2155	/	9.188
	=	0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Valeo Pharma Inventory Turnover Related Terms

Valeo Pharma Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Valeo Pharma's Inventory Turnover can be seen below:

Valeo Pharma Inventory Turnover Chart

Valeo Pharma Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Inventory Turnover

Get a 7-Day Free Trial

15.76

8.44

2.26

2.33

4.03

Valeo Pharma Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Inventory Turnover	Get a 7-Day Free Trial															0.80	0.95	1.14	1.36	1.65

12GF Score

Valeo Pharma Inc VPHIF

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Valeo Pharma Inventory Turnover Calculation

Valeo Pharma's Inventory Turnover for the fiscal year that ended in Oct. 2023 is calculated as

	Inventory Turnover (A: Oct. 2023 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Oct. 2023 )	/ (	(Total Inventories (A: Oct. 2022 )	+	Total Inventories (A: Oct. 2023 ))	/	count )
=	29.779	/ (	(7.291	+	7.472)	/	2 )
=	29.779	/	7.3815
=	4.03

Valeo Pharma's Inventory Turnover for the quarter that ended in Jul. 2024 is calculated as

	Inventory Turnover (Q: Jul. 2024 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Jul. 2024 )	/ (	(Total Inventories (Q: Apr. 2024 )	+	Total Inventories (Q: Jul. 2024 ))	/	count )
=	6.976	/ (	(4.831	+	3.6)	/	2 )
=	6.976	/	4.2155
=	1.65

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 1.65 mean?

Valeo Pharma (VPHIF) has a Inventory Turnover of 1.65 as of Jul. 2024. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Valeo Pharma and its competitors.

Is Valeo Pharma's Inventory Turnover too high?

Valeo Pharma's current Inventory Turnover is 1.65. Overall, Valeo Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.

How does Valeo Pharma's Inventory Turnover compare to ZTS?

Valeo Pharma's Inventory Turnover of 1.65 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Drug Manufacturers company?

A good Inventory Turnover depends on the Drug Manufacturers industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Valeo Pharma and its competitors. Valeo Pharma's current Inventory Turnover is 1.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Valeo Pharma stock overvalued right now?

Valeo Pharma (VPHIF) has a current Inventory Turnover of 1.65. The current Inventory Turnover is 1.65. Valeo Pharma's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Valeo Pharma (VPHIF), the current Inventory Turnover is 1.65 as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Valeo Pharma Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies XCNQ:CANN TSX:XLY XCNQ:XTRX TSXV:MPH XCNQ:BAMM TSX:CTX NEOE:TILT XCNQ:MVMD XCNQ:VIN XCNQ:PWR ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692

Address 16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9

Website https://www.valeopharma.com

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

12GF Score

Get the complete analysis for VPHIF

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00

Price

View VPHIF Analysis

See Inventory Turnover data for all stocks →